Bio-Techne Corporation (TECH.MX)
| Previous close | 1,467.32 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 0 |
| Market cap | 206.487B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | 51.59 |
| EPS (TTM) | 25.40 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | N/A |
Simply Wall St.Bio-Techne Third Quarter 2024 Earnings: Beats Expectations
Bio-Techne ( NASDAQ:TECH ) Third Quarter 2024 Results Key Financial Results Revenue: US$303.4m (up 3.2% from 3Q 2023...
PR NewswireBIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities Health Care Conference on Tuesday, May 14, 2024, at 2:20 p.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
- PR Newswire
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
